Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 108 participants.
Also called NCT06471543
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 108 participants
- Sponsor
- Ikaria Bioscience Pty Ltd
- Registry
-
NCT06471543
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06471543. Randomized; quadruple masking; primary purpose treatment. Start 2024-09-30 (actual); primary completion 2026-06-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects
- Condition
- Hypertriglyceridemia
- Condition
- Familial Chylomicronemia Syndrome
- Intervention (Drug)
- RN0361
- Lead sponsor
- Ikaria Bioscience Pty Ltd
Record details
- Record id
cardio:ct-nct06471543- Content hash
1698993c3533aa9cb09d0b0383dae5e43b57ed982e7f8cd22174af8685f83535